The US National Institutes of Health (NIH) partnered with the pharmaceutical firm, Sanofi, to produce an antibody capable of attacking 99 percent of HIV strains. This new study is made Continue Reading
The US National Institutes of Health (NIH) partnered with the pharmaceutical firm, Sanofi, to produce an antibody capable of attacking 99 percent of HIV strains. This new study is made Continue Reading